Inventor
LAUFER STEFAN
DE22 patents
⚠️ This page may combine multiple inventors who share the name “LAUFER STEFAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCKLE GMBH
12 patentsUS5958943ASep 28, 1999
A!-anellated pyrrole derivatives and their use in pharmacology
MERCKLE GMBH50 citations90
US5942535AAug 24, 1999
a!-Annelated pyrrole derivatives and pharmaceutical use thereof
MERCKLE GMBH54 citations90
US5939415AAug 17, 1999
A!-annellated pyrrole derivatives and their use in pharmacology
MERCKLE GMBH52 citations90
US6936632B2Aug 30, 2005
Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof
MERCKLE GMBH9 citations69
US6432988B1Aug 13, 2002
2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine
MERCKLE GMBH10 citations68
US7442713B2Oct 28, 2008
2-thio-substituted imidazole derivatives and their use in pharmaceutics
MERCKLE GMBH3 citations61
US7078535B2Jul 18, 2006
Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid
MERCKLE GMBH2 citations59
US6867211B2Mar 15, 2005
4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
MERCKLE GMBH2 citations58
US6417371B1Jul 9, 2002
Process for preparing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-acetic acid
MERCKLE GMBH4 citations58
US7253191B2Aug 7, 2007
2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
MERCKLE GMBH6 citations57
US8034837B2Oct 11, 2011
Polymorphic form of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid
MERCKLE GMBH0 citations45
US6878738B1Apr 12, 2005
Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use
MERCKLE GMBH0 citations39
HEPAREGENIX GMBH
6 patentsUS11912701B2Feb 27, 2024
Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
HEPAREGENIX GMBH2 citations67
US11040027B2Jun 22, 2021
Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
HEPAREGENIX GMBH5 citations67
US11731968B2Aug 22, 2023
Tricyclic protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
HEPAREGENIX GMBH1 citations56
US12264158B2Apr 1, 2025
Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
HEPAREGENIX GMBH0 citations55
US11858927B2Jan 2, 2024
Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
HEPAREGENIX GMBH1 citations55
US12466826B2Nov 11, 2025
3-benzoyl-1H-pyrrolo[2,3-b]pyridine derivatives as MKK4 inhibitors for treating liver diseases
HEPAREGENIX GMBH0 citations50